VALE, JR.; Wylie W.
Patent Applications and Registrations
Patent applications and USPTO patent grants for VALE, JR.; Wylie W..The latest application filed is for "urocortin 2 analogs and uses thereof".
Company Profile
1.68.12
- VALE, JR.; Wylie W. - US
- Vale, Jr.; Wylie W. - N/A
- Vale, Jr.; Wylie W. - Carson City NV
- Vale, Jr.; Wylie W. - La Jolla CA
- Vale, Jr.; Wylie W. - LaJolla CA
Patent Activity
| Patent | Date |
|---|---|
| Urocortin 2 Analogs And Uses Thereof App 20180271945 - VALE, JR.; Wylie W. ; et al. | 2018-09-27 |
| Methods For Treatment And Prevention Of Tauopathies And Amyloid Beta Amyloidosis By Modulating Crf Receptor Signaling App 20170151245 - RISSMAN; Robert A. ; et al. | 2017-06-01 |
| Urocortin 2 analogs and uses thereof Grant 9,572,866 - Vale, Jr. , et al. February 21, 2 | 2017-02-21 |
| Urocortin-iii And Uses Thereof App 20160375102 - VALE, JR.; Wylie W. ; et al. | 2016-12-29 |
| Urocortin-III and uses thereof Grant 9,388,229 - Vale, Jr. , et al. July 12, 2 | 2016-07-12 |
| Urocortin 2 Analogs And Uses Thereof App 20160022780 - VALE, JR.; Wylie W. ; et al. | 2016-01-28 |
| Urocortin 2 Analogs And Uses Thereof App 20150315257 - VALE, JR.; Wylie W. ; et al. | 2015-11-05 |
| Urocortin-iii And Uses Thereof App 20140288161 - VALE, JR.; Wylie W. ; et al. | 2014-09-25 |
| Urocortin-III and uses thereof Grant 8,669,092 - Vale, Jr. , et al. March 11, 2 | 2014-03-11 |
| Urocortin-iii And Uses Thereof App 20140004603 - VALE, JR.; Wylie W. ; et al. | 2014-01-02 |
| Urocortin-III and uses thereof Grant 8,445,425 - Vale, Jr. , et al. May 21, 2 | 2013-05-21 |
| Urocortin-iii And Uses Thereof App 20120270792 - Vale, JR.; Wylie W. ; et al. | 2012-10-25 |
| Urocortin 2 Analogs And Uses Thereof App 20120238509 - Vale, JR.; Wylie W. ; et al. | 2012-09-20 |
| Urocortin-III and uses thereof Grant 8,084,413 - Vale, Jr. , et al. December 27, 2 | 2011-12-27 |
| Urocortin proteins and uses thereof Grant 8,044,025 - Vale, Jr. , et al. October 25, 2 | 2011-10-25 |
| Antibodies to activin receptor Grant 7,893,213 - Mathews , et al. February 22, 2 | 2011-02-22 |
| Structure-based modulators of B1 G-protein coupled receptors Grant 7,869,958 - Royappa , et al. January 11, 2 | 2011-01-11 |
| CRFR1 selective ligands Grant 7,851,588 - Rivier , et al. December 14, 2 | 2010-12-14 |
| Cloning And Recombinant Production Of Receptor(s) Of The Activin/tgf-beta Superfamily App 20100016558 - Mathews; Lawrence S. ; et al. | 2010-01-21 |
| Urocortin-iii And Uses Thereof App 20090156493 - Vale, JR.; Wylie W. ; et al. | 2009-06-18 |
| Crfr1 Selective Ligands App 20090149629 - Rivier; Jean E.F. ; et al. | 2009-06-11 |
| Urocortin-III and uses thereof Grant 7,459,427 - Vale, Jr. , et al. December 2, 2 | 2008-12-02 |
| Cloning and recombinant production of CRF receptor(s) Grant 7,358,225 - Perrin , et al. April 15, 2 | 2008-04-15 |
| Urocortin-III and uses thereof Grant 6,953,838 - Vale, Jr. , et al. October 11, 2 | 2005-10-11 |
| Urocortin proteins and uses thereof Grant 6,838,274 - Vale, Jr. , et al. January 4, 2 | 2005-01-04 |
| Methods of screening for compounds that bind to activin receptor Grant 6,835,544 - Mathews , et al. December 28, 2 | 2004-12-28 |
| Urocortin-III and uses thereof Grant 6,812,210 - Vale, Jr. , et al. November 2, 2 | 2004-11-02 |
| Cloning and recombinant production of CFR receptor(s) Grant 6,638,905 - Perrin , et al. October 28, 2 | 2003-10-28 |
| Recombinant vertebrate activin receptors Grant 6,162,896 - Mathews , et al. December 19, 2 | 2000-12-19 |
| Peptides of melanin concentrating hormone precursor Grant 5,530,095 - Vaughn , et al. June 25, 1 | 1996-06-25 |
| Cyclic CRF analogs Grant 5,493,006 - de Miranda , et al. February 20, 1 | 1996-02-20 |
| GnRH analogs Grant 5,296,468 - Hoeger , et al. March 22, 1 | 1994-03-22 |
| CRF antagonists Grant 5,245,009 - Kornreich , et al. * September 14, 1 | 1993-09-14 |
| CRF analogs Grant 5,235,036 - Kornreich , et al. August 10, 1 | 1993-08-10 |
| GnRH analogs Grant 5,169,932 - Hoeger , et al. December 8, 1 | 1992-12-08 |
| CRF analog conjugates Grant 5,132,111 - Vale, Jr. , et al. July 21, 1 | 1992-07-21 |
| Cyclic GnRH antagonists Grant 5,064,939 - Rivier , et al. November 12, 1 | 1991-11-12 |
| Melanin-concentrating hormones Grant 5,049,655 - Vaughan , et al. September 17, 1 | 1991-09-17 |
| Cyclic GRF analogs Grant 5,043,322 - Rivier , et al. August 27, 1 | 1991-08-27 |
| Potentiation of erythropoiesis Grant 5,032,507 - Yu , et al. July 16, 1 | 1991-07-16 |
| FSH-releasing peptides Grant 4,973,577 - Vale, Jr. , et al. November 27, 1 | 1990-11-27 |
| GRF analogs VI Grant 4,784,987 - Rivier , et al. November 15, 1 | 1988-11-15 |
| GnRH antagonists VIII Grant 4,740,500 - Vale, Jr. , et al. April 26, 1 | 1988-04-26 |
| Human inhibin Grant 4,737,578 - Evans , et al. April 12, 1 | 1988-04-12 |
| GRF analogs IIIb Grant 4,728,726 - Rivier , et al. * March 1, 1 | 1988-03-01 |
| GnRH antagonists V Grant 4,689,396 - Roeske , et al. * August 25, 1 | 1987-08-25 |
| GnRH antagonists IX Grant 4,661,472 - Rivier , et al. April 28, 1 | 1987-04-28 |
| GnRH antagonists VII Grant 4,652,550 - Rivier , et al. March 24, 1 | 1987-03-24 |
| Hypothalamic GRF agonists Grant 4,628,043 - Spiess , et al. December 9, 1 | 1986-12-09 |
| GRF analogs II Grant 4,626,523 - Vale, Jr. , et al. December 2, 1 | 1986-12-02 |
| CRF antagonists Grant 4,605,642 - Rivier , et al. August 12, 1 | 1986-08-12 |
| Rat hypothalamic GRF Grant 4,595,676 - Spiess , et al. June 17, 1 | 1986-06-17 |
| GnRH Antagonists IV Grant 4,569,927 - Rivier , et al. February 11, 1 | 1986-02-11 |
| GnRH Antagonists VI Grant 4,565,804 - Rivier , et al. January 21, 1 | 1986-01-21 |
| Human pancreatic GRF Grant 4,563,352 - Rivier , et al. * January 7, 1 | 1986-01-07 |
| Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals Grant 4,530,838 - Evans , et al. July 23, 1 | 1985-07-23 |
| GRF Analogs Grant 4,529,595 - Rivier , et al. July 16, 1 | 1985-07-16 |
| GRF Analogs IV Grant 4,528,190 - Vale, Jr. , et al. July 9, 1 | 1985-07-09 |
| GRF Analogs III Grant 4,518,586 - Rivier , et al. May 21, 1 | 1985-05-21 |
| Treatment of male mammals Grant 4,489,061 - Rivier , et al. * December 18, 1 | 1984-12-18 |
| rCRF and analogs Grant 4,489,163 - Rivier , et al. December 18, 1 | 1984-12-18 |
| GnRH Antagonists II Grant 4,444,759 - Rivier , et al. April 24, 1 | 1984-04-24 |
| Analogs of somatostatin Grant 4,428,942 - Rivier , et al. January 31, 1 | 1984-01-31 |
| CRF And analogs Grant 4,415,558 - Vale, Jr. , et al. November 15, 1 | 1983-11-15 |
| GnRH antagonists Grant 4,409,208 - Rivier , et al. * October 11, 1 | 1983-10-11 |
| Analogs of extended N-terminal somatostatin Grant 4,393,050 - Vale, Jr. , et al. July 12, 1 | 1983-07-12 |
| Peptides affecting gonadal function Grant 4,382,922 - Rivier , et al. May 10, 1 | 1983-05-10 |
| Contraceptive treatment of male mammals Grant 4,377,574 - Rivier , et al. March 22, 1 | 1983-03-22 |
| Pharmaceutically active peptides Grant 4,372,884 - Brown , et al. February 8, 1 | 1983-02-08 |
| LRF Antagonists Grant 4,307,083 - Rivier , et al. December 22, 1 | 1981-12-22 |
| Peptides which effect release of hormones Grant RE30,548 - Vale, Jr. , et al. March 17, 1 | 1981-03-17 |
| Water-soluble peptides affecting gonadal function Grant 4,244,946 - Rivier , et al. January 13, 1 | 1981-01-13 |
| Peptides which inhibit gonadal function Grant 4,215,038 - Rivier , et al. July 29, 1 | 1980-07-29 |
| Peptides with para-substituted phenylalanine Grant 4,211,693 - Rivier , et al. July 8, 1 | 1980-07-08 |
| Peptides having analgesic and thermoregulative properties Grant 4,207,311 - Brown , et al. June 10, 1 | 1980-06-10 |
| Somatostatin analogs with dissociated biological activities Grant 4,133,782 - Vale, Jr. , et al. January 9, 1 | 1979-01-09 |
| Peptides which effect release of hormones Grant 4,105,603 - Vale, Jr. , et al. August 8, 1 | 1978-08-08 |
| LH-RH Analogs Grant 4,072,668 - Amoss , et al. February 7, 1 | 1978-02-07 |
| Somatostatin and acylated des-(ala.sup.1, gly.sup.2) derivatives thereof Grant 3,904,594 - Guillemin , et al. September 9, 1 | 1975-09-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 